Gene-Expression Diagnostics Can Identify Risk of Poor Outcomes in Patients with Sepsis
An observational study in Critical Care (London, England) aimed to identify subgroups of septic patients at high risk of poor outcome using a rapid, multiplex RNA-based test. The study included 357 patients with sepsis. Patients were assigned into high and low risk groups using 2 different models previously developed for the Immune-Profiling Panel prototype on the bioMérieux FilmArray system. For model 1, 90-day mortality was higher in the high-risk group at each of 3 sampling times (S1: 35% vs. 24%, P = 0.04; S2: 43% vs. 20%, P < 0.001; S3: 52% vs. 24%, P = 0.007). For model 2, mortality was significantly different only at the second sampling time (S1: 30% vs. 27%, P = 0.77; S2: 34% vs. 14%, P = 0.002; S3: 35% vs. 23%, P = 0.13).